Christine M. Ho

1.3k total citations · 1 hit paper
13 papers, 865 citations indexed

About

Christine M. Ho is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Christine M. Ho has authored 13 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Hematology and 6 papers in Immunology. Recurrent topics in Christine M. Ho's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Christine M. Ho is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Christine M. Ho collaborates with scholars based in United States, Spain and India. Christine M. Ho's co-authors include Vivien W. Chan, Lisa M. Coussens, Nancy Pryer, Dylan Daniel, E. Shelley Hwang, Hope S. Rugo, Brian Ruffell, Philip L. McCarthy, Theresa Hahn and Sophia Balderman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Cell.

In The Last Decade

Christine M. Ho

12 papers receiving 861 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells

2014 758 citations Brian Ruffell, Vivien W. Chan et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine M. Ho United States	6	645	541	227	63	59	13	865
Steven K. Grossenbacher United States	15	583 0.9×	514 1.0×	175 0.8×	69 1.1×	68 1.2×	21	855
Jonathan J. Hodgins Canada	5	631 1.0×	530 1.0×	150 0.7×	55 0.9×	30 0.5×	7	803
Anushruti Sarvaria United Kingdom	4	566 0.9×	448 0.8×	149 0.7×	66 1.0×	116 2.0×	4	755
Jérôme Mastio United States	10	631 1.0×	346 0.6×	319 1.4×	90 1.4×	84 1.4×	11	908
Qods Lahmar Belgium	6	527 0.8×	318 0.6×	168 0.7×	40 0.6×	38 0.6×	6	637
Haofan Jin China	13	361 0.6×	345 0.6×	176 0.8×	62 1.0×	27 0.5×	25	681
Erik Ames United States	15	740 1.1×	488 0.9×	178 0.8×	51 0.8×	160 2.7×	26	965
Hanne Vos Belgium	4	359 0.6×	338 0.6×	261 1.1×	107 1.7×	35 0.6×	12	687
Erika Falisi Italy	9	1.2k 1.8×	560 1.0×	217 1.0×	79 1.3×	65 1.1×	10	1.3k
Anusha-Preethi Ganesan United States	6	639 1.0×	581 1.1×	297 1.3×	111 1.8×	25 0.4×	9	1.0k

Countries citing papers authored by Christine M. Ho

Since Specialization

Citations

This map shows the geographic impact of Christine M. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine M. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine M. Ho more than expected).

Fields of papers citing papers by Christine M. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine M. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine M. Ho. The network helps show where Christine M. Ho may publish in the future.

Co-authorship network of co-authors of Christine M. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Christine M. Ho. A scholar is included among the top collaborators of Christine M. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine M. Ho. Christine M. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ho, Christine M., Paul K. Wallace, Kristopher Attwood, et al.. (2022). Immune cell differences between patients in different stages of monoclonal plasma cell disorders.. Journal of Clinical Oncology. 40(16_suppl). 8065–8065. 2 indexed citations

Landsburg, Daniel J., Matthew J. Frigault, S.R. Foley, et al.. (2022). Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry. Blood. 140(Supplement 1). 1584–1587. 15 indexed citations

Landsburg, Daniel J., Matthew J. Frigault, Zhen‐Huan Hu, et al.. (2021). Real-World Efficacy and Safety Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry. Blood. 138(Supplement 1). 429–429. 10 indexed citations

Herr, Megan M., Shabnam Rehman, Yali Zhang, et al.. (2021). Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplantation Predicts Healthcare Utilization and Survival. Transplantation and Cellular Therapy. 27(10). 875.e1–875.e9. 1 indexed citations

Herr, Megan M., George L. Chen, Maureen Ross, et al.. (2020). Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell-Associated Encephalopathy (ICE) Score. Biology of Blood and Marrow Transplantation. 26(11). e271–e274. 21 indexed citations

Herr, Megan M., Pallawi Torka, Yali Zhang, et al.. (2019). Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant. Bone Marrow Transplantation. 55(1). 77–85. 3 indexed citations

Holstein, Sarah A., Hervé Avet‐Loiseau, Theresa Hahn, et al.. (2017). BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee. Biology of Blood and Marrow Transplantation. 24(4). 641–648. 13 indexed citations

Ho, Christine M., Philip L. McCarthy, Paul K. Wallace, et al.. (2017). Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Advances. 1(15). 1056–1066. 38 indexed citations

Wallace, Paul K., Theresa Hahn, Yali Zhang, et al.. (2016). Evolution of Multiparametric Flow Cytometry Testing for Minimal Residual Disease Assessment in Multiple Myeloma and Its Impact on Clinical Outcomes: A Single Institution Experience. Blood. 128(22). 2274–2274. 1 indexed citations

10.

Torka, Pallawi, Paul K. Wallace, Yali Zhang, et al.. (2015). Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma. Blood. 126(23). 3173–3173. 1 indexed citations

11.

Ruffell, Brian, Vivien W. Chan, Christine M. Ho, et al.. (2014). Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells. Cancer Cell. 26(5). 623–637. 758 indexed citations breakdown →

12.

Ho, Christine M. & James N. Butera. (2011). Acute myeloid leukemia in the elderly.. PubMed. 94(1). 7–9. 2 indexed citations

13.

Ho, Christine M. & James N. Butera. (2009). Update on myelodysplastic syndrome.. PubMed. 92(9). 315–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact